Neurodevelopmental and associated changes in a patient with Xp22.31 duplication

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Li F, Shen Y, Köhler U, Sharkey FH, Menon D, Coulleaux L, Malan V, Rio M, McMullan DJ, Cox H, Fagan KA, Gaunt L, Metcalfe K, Heinrich U, Hislop G, Maye U, Sutcliffe M, Wu BL, Thiel BD, Mulchandani S, Conlin LK, Spinner NB, Murphy KM, Batista DAS (2010) Interstitial microduplication of Xp22.31: causative of intellectual disability or benign copy number variant? Eur J Med Genet 53:93–99

    Article  Google Scholar 

  2. 2.

    Furrow A, Theisen A, Velsher L, Bawle EV, Sastry S, Mendelsohn NJ et al (2011) Duplication of the STS region in males is a benign copy-number variant. Am J Med Genet A 155A:1972–1975

    Article  Google Scholar 

  3. 3.

    Liu P, Erez A, Nagamani SC, Bi W, Carvalho CM, Simmons AD et al (2011) Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Hum Mol Genet 20:1975–1988

    Article  Google Scholar 

  4. 4.

    Esplin ED, Li B, Slavotinek A, Novelli A, Battaglia A, Clark R, Curry C, Hudgins L (2014) Nine patients with Xp22.31 microduplication, cognitive deficits, seizures, and talipes anomalies. Am J Med Genet A 164A:2097–2103

    Article  Google Scholar 

  5. 5.

    Addis L, Sproviero W, Thomas SV, Caraballo RH, Newhouse SJ, Gomez K, Hughes E, Kinali M, McCormick D, Hannan S, Cossu S, Taylor J, Akman CI, Wolf SM, Mandelbaum DE, Gupta R, van der Spek RA, Pruna D, Pal DK (2018) Identification of new risk factors for rolandic epilepsy: CNV at Xp22.31 and alterations at cholinergic synapses. J Med Genet 55:607–616

    CAS  Article  Google Scholar 

  6. 6.

    Liu P, Erez A, Nagamani SC, Bi W, Carvalho CM, Simmons AD et al (2011) Copy number gain at Xp22.31 includes complex duplicationrearrangements and recurrent triplications. Hum Mol Genet 20:1975–1988

    Article  Google Scholar 

  7. 7.

    Sorokin A, Szekely A, Jabbari B (2013) Tremor as a prominent feature in Xp22.31 microduplication: a novel association. Neurology 80; supplement 7(p05.040)

  8. 8.

    Pang T, Atefy R, Sheen V (2008) Malformations of cortical development. Neurologist 14:181–191

    Article  Google Scholar 

Download references

Acknowledgments

The present case report is dedicated to the memory of Dr. John Fernandes who was the primary pathologist contributing to this case report.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jian-Qiang Lu.

Ethics declarations

Conflict of interest

Dr. Mark Tarnopolsky is the CEO of Exerkine Corporation and the company is working on therapies that target mitochondrial dysfunction; the remaining authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

MacColl, C., Stein, N., Tarnopolsky, M. et al. Neurodevelopmental and associated changes in a patient with Xp22.31 duplication. Neurol Sci 41, 713–716 (2020). https://doi.org/10.1007/s10072-019-04065-1

Download citation